Oxidative Stress and Inflammation in Hepatic Diseases: Therapeutic Possibilities of N-Acetylcysteine
Authors:
- Kívia Queiroz De AndradeKAKívia Queiroz De Andrade
- Fabiana Andréa MouraFMFabiana Andréa Moura
- John Marques Dos SantosJSJohn Marques Dos Santos
- Orlando Roberto Pimentel De AraújoOAOrlando Roberto Pimentel De Araújo
- Juliana Célia De Farias SantosJSJuliana Célia De Farias Santos
- Marília Oliveira Fonseca GoulartMarília Oliveira Fonseca Goulart
Top Cited Papers
Open Access
- 18 December 2015
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 16 (12) , 30269-30308
Abstract
Liver disease is highly prevalent in the world. Oxidative stress (OS) and inflammation are the most important pathogenetic events in liver diseases, regardless the different etiology and natural course. N-acetyl-l-cysteine (the active form) (NAC) is being studied in diseases characterized by increased OS or decreased glutathione (GSH) level. NAC acts mainly on the supply of cysteine for GSH synthesis. The objective of this review is to examine experimental and clinical studies that evaluate the antioxidant and anti-inflammatory roles of NAC in attenuating markers of inflammation and OS in hepatic damage. The results related to the supplementation of NAC in any form of administration and type of study are satisfactory in 85.5% (n = 59) of the cases evaluated (n = 69, 100%). Within this percentage, the dosage of NAC utilized in studies in vivo varied from 0.204 up to 2 g/kg/day. A standard experimental design of protection and treatment as well as the choice of the route of administration, with a broader evaluation of OS and inflammation markers in the serum or other biological matrixes, in animal models, are necessary. Clinical studies are urgently required, to have a clear view, so that, the professionals can be sure about the effectiveness and safety of NAC prescription.Keywords
Funding Information
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (458114/2014-6, 407963/2013-8, 484044/2011-7)
This publication has 253 references indexed in Scilit:
- Biological markers of oxidative stress: Applications to cardiovascular research and practiceRedox Biology, 2013
- N-acetylcysteine reduces inflammation in the small intestine by regulating redox, EGF and TLR4 signalingAmino Acids, 2012
- Molecular pathogenesis of hepatic fibrosis and current therapeutic approachesChemico-Biological Interactions, 2011
- Nitric Oxide and Redox Regulation in the Liver: Part II. Redox Biology in Pathologic Hepatocytes and Implications for InterventionJournal of Surgical Research, 2011
- Oral N-acetylcysteine rescues lethality of hepatocyte-specific Gclc-knockout mice, providing a model for hepatic cirrhosisJournal of Hepatology, 2010
- Oxidative stress, inflammation, and cancer: How are they linked?Free Radical Biology and Medicine, 2010
- Role of free radicals in liver diseasesHepatology International, 2009
- Kupffer cells in non-alcoholic fatty liver disease: The emerging viewJournal of Hepatology, 2009
- Carbon tetrachloride-induced liver damage in asialoglycoprotein receptor-deficient miceBiochemical Pharmacology, 2009
- Factors in the Pathophysiology of the Liver Ischemia-Reperfusion InjuryJournal of Surgical Research, 2008